The β3-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans

Brian S. Finlin(Diabetes Australia), Philip A. Kern(Diabetes Australia)
Journal of Clinical Investigation
January 21, 2020
Cited by 255


Related Papers